BEAVERTON, Ore. , Oct. 24, 2025 /PRNewswire/ -- YorLabs, Inc., a medical technology company pioneering next-generation intracardiac imaging solutions for electrophysiology (EP) and interventional cardiology (IC) procedures, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the company's YorLabs Intracardiac Imaging System - a first-of-its-kind, zero-capex ultrasound platform designed to simplify workflow, reduce cost, and enhance procedural efficiency inside the cath lab.

The YorLabs system enables single-operator control and provides high-resolution, real-time imaging for a wide range of intracardiac procedures. Its compact, wireless system integrates seamlessly into cath labs, representing a fundamental leap forward in how physicians vi

See Full Page